ArticleEuropean radiology2024

Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.

Cong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.